| dc.contributor.author |
DiMasi, Joseph A |
|
| dc.contributor.author |
Grabowski, Henry G |
|
| dc.contributor.author |
Hansen, Ronald W |
|
| dc.coverage.spatial |
United States |
|
| dc.date.accessioned |
2016-09-13T07:48:34Z |
|
| dc.date.issued |
2015-05-14 |
|
| dc.identifier |
http://www.ncbi.nlm.nih.gov/pubmed/25970070 |
|
| dc.identifier.uri |
https://hdl.handle.net/10161/12747 |
|
| dc.language |
eng |
|
| dc.publisher |
Massachusetts Medical Society |
|
| dc.relation.ispartof |
N Engl J Med |
|
| dc.relation.isversionof |
10.1056/NEJMc1504317 |
|
| dc.subject |
Drug Costs |
|
| dc.subject |
Drug Discovery |
|
| dc.subject |
Drug Industry |
|
| dc.subject |
Financing, Government |
|
| dc.title |
The cost of drug development. |
|
| dc.type |
Journal article |
|
| duke.contributor.id |
Grabowski, Henry G|0099498 |
|
| pubs.author-url |
http://www.ncbi.nlm.nih.gov/pubmed/25970070 |
|
| pubs.begin-page |
1972 |
|
| pubs.issue |
20 |
|
| pubs.organisational-group |
Duke |
|
| pubs.organisational-group |
Economics |
|
| pubs.organisational-group |
Trinity College of Arts & Sciences |
|
| pubs.publication-status |
Published |
|
| pubs.volume |
372 |
|
| dc.identifier.eissn |
1533-4406 |
|
